Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C30H29N5O4S |
Molecular Weight | 555.647 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CN(CCCCN3C(=O)NC4=C(SC5=C4N=C(C=N5)C6=CC=CC=C6)C3=O)C[C@@]1([H])C7=C(OC2)C=CC=C7OC
InChI
InChIKey=WDTAYDBPNYFWDR-WOJBJXKFSA-N
InChI=1S/C30H29N5O4S/c1-38-22-10-7-11-23-24(22)20-16-34(15-19(20)17-39-23)12-5-6-13-35-29(36)27-25(33-30(35)37)26-28(40-27)31-14-21(32-26)18-8-3-2-4-9-18/h2-4,7-11,14,19-20H,5-6,12-13,15-17H2,1H3,(H,33,37)/t19-,20-/m1/s1
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs. | 2002 Feb |
|
Preclinical pharmacology of fiduxosin, a novel alpha(1)-adrenoceptor antagonist with uroselective properties. | 2002 Feb |
|
Effect of food on the pharmacokinetics of fiduxosin in healthy male subjects. | 2002 Jan-Mar |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11805207
Fiduxosin had higher affinity for cloned human alpha(1a)- (0.16 nM) and alpha(1d)-adrenoceptors (0.92 nM) in radioligand binding studies compared with alpha(1b)-adrenoceptors (25 nM).
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29713
Created by
admin on Fri Dec 15 16:25:36 GMT 2023 , Edited by admin on Fri Dec 15 16:25:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
172307
Created by
admin on Fri Dec 15 16:25:36 GMT 2023 , Edited by admin on Fri Dec 15 16:25:36 GMT 2023
|
PRIMARY | |||
|
208993-54-8
Created by
admin on Fri Dec 15 16:25:36 GMT 2023 , Edited by admin on Fri Dec 15 16:25:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL1256183
Created by
admin on Fri Dec 15 16:25:36 GMT 2023 , Edited by admin on Fri Dec 15 16:25:36 GMT 2023
|
PRIMARY | |||
|
300000034223
Created by
admin on Fri Dec 15 16:25:36 GMT 2023 , Edited by admin on Fri Dec 15 16:25:36 GMT 2023
|
PRIMARY | |||
|
C447622
Created by
admin on Fri Dec 15 16:25:36 GMT 2023 , Edited by admin on Fri Dec 15 16:25:36 GMT 2023
|
PRIMARY | |||
|
C65682
Created by
admin on Fri Dec 15 16:25:36 GMT 2023 , Edited by admin on Fri Dec 15 16:25:36 GMT 2023
|
PRIMARY | |||
|
7951
Created by
admin on Fri Dec 15 16:25:36 GMT 2023 , Edited by admin on Fri Dec 15 16:25:36 GMT 2023
|
PRIMARY | |||
|
DTXSID401017163
Created by
admin on Fri Dec 15 16:25:36 GMT 2023 , Edited by admin on Fri Dec 15 16:25:36 GMT 2023
|
PRIMARY | |||
|
W9O92HYT6I
Created by
admin on Fri Dec 15 16:25:36 GMT 2023 , Edited by admin on Fri Dec 15 16:25:36 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)